TARGETING OF DRUGS: IMPLICATIONS IN MEDICINE

[1]  P. Casellas,et al.  Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells , 1981, Nature.

[2]  S. Olsnes.  Directing toxins to cancer cells , 1981, Nature.

[3]  G. Gregoriadis.  Liposomes: A role in vaccines? , 1981 .

[4]  S. Kaye,et al.  The effect of liposome (phospholipid vesicle) entrapment of actinomycin D and methotrexate on the in vivo treatment of sensitive and resistant solid murine tumours. , 1981, European journal of cancer.

[5]  P. Schlesinger,et al.  L-Fucose-terminated glycoconjugates are recognized by pinocytosis receptors on macrophages. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Yatvin,et al.  pH-sensitive liposomes: possible clinical implications. , 1980, Science.

[7]  Jacques Barbet,et al.  Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A , 1980, Nature.

[8]  G. Gregoriadis,et al.  The effect of the cholesterol content of small unilamellar liposomes on the fate of their lipid components in vitro. , 1980, Life sciences.

[9]  D. Volsky,et al.  Alteration of lymphocyte surface properties by insertion of foreign functional components of plasma membrane. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Torchilin,et al.  Incorporation of hydrophilic protein modified with hydrophobic agent into liposome membrane. , 1980, Biochimica et biophysica acta.

[11]  P. Schlesinger,et al.  The role of extra-hepatic tissues in the receptor-mediated plasma clearance of glycoproteins terminated by mannose or N-acetylglucosamine. , 1980, The Biochemical journal.

[12]  B. Bachhawat,et al.  Grafting of different glycosides on the surface of liposomes and its effect on the tissue distribution of 125I-labelled gamma-globulin encapsulated in liposomes. , 1980, Biochimica et biophysica acta.

[13]  M. Roskopf,et al.  Distribution of leukocytes labeled with In-111 oxine in dogs with acute inflammatory lesions. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  P. Couvreur,et al.  Actinomycin D absorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor. , 1980, European journal of cancer.

[15]  T. Heath,et al.  Antibody targeting of liposomes: cell specificity obtained by conjugation of F(ab')2 to vesicle surface. , 1980, Science.

[16]  K. Widder,et al.  In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres. , 1980, Cancer research.

[17]  A. Attie,et al.  Metabolism of native and of lactosylated human low density lipoprotein: evidence for two pathways for catabolism of exogenous proteins in rat hepatocytes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Gregoriadis,et al.  The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation , 1980, FEBS letters.

[19]  R. Chalmers,et al.  Organic-acid transport in resealed haemoglobin-containing human erythrocyte 'ghosts'. , 1980, The Biochemical journal.

[20]  L. Huang,et al.  Monoclonal antibody covalently coupled with fatty acid. A reagent for in vitro liposome targeting. , 1980, The Journal of biological chemistry.

[21]  L. Murphy,et al.  The binding of tamoxifen to human mammary carcinoma cytosol. , 1980, European journal of cancer.

[22]  D. Neville,et al.  Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Isakson,et al.  Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Green,et al.  CLINICAL TRIAL OF DESFERRIOXAMINE ENTRAPPED IN RED CELL GHOSTS , 1980, The Lancet.

[25]  A. Trouet,et al.  Primaquine liposomes in the chemotherapy of experimental murine malaria. , 1980, Annals of tropical medicine and parasitology.

[26]  D. Gilliland,et al.  Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Payment,et al.  Reconstitution of rubella hemagglutinin on liposomes. , 1980, Canadian journal of microbiology.

[28]  J. D. de Vries,et al.  Selective inhibition of ectromelia virus DNA synthesis in hepatocytes by adenine‐9‐β‐D‐arabinofuranoside (ara‐A) and adenine‐9‐β‐D‐arabinofuranoside 5′‐monophosphate (ara‐AMP) conjugated to asialofetuin , 1980, FEBS letters.

[29]  E. Mekada,et al.  Hybrid toxin of the A chain of ricin toxin and a subunit of Wistaria floribunda lectin. Possible importance of the hydrophobic region for entry of toxin into the cell. , 1980, The Journal of biological chemistry.

[30]  M. Forni,et al.  Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation. , 1980, The New England journal of medicine.

[31]  P. Beaumier,et al.  Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[32]  I. Fidler.  Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. , 1980, Science.

[33]  D. Solter,et al.  Localization of I-131-labeled tumor-specific monoclonal antibody in the tumor-bearing BALB/c mouse. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  J. Katzenellenbogen,et al.  Protease-activated "prodrugs" for cancer chemotherapy. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[35]  K. E. Williams,et al.  Preparation and properties of liposome-associated gentamicin , 1980, Antimicrobial Agents and Chemotherapy.

[36]  H. Kolb,et al.  Analysis of lectin-dependent recognition of desialylated erythrocytes by Kupffer cells. , 1980, The Biochemical journal.

[37]  G. Gregoriadis,et al.  Cholesterol content of small unilamellar liposomes controls phospholipid loss to high density lipoproteins in the presence of serum , 1980, FEBS letters.

[38]  L. Lesko,et al.  Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo. , 1980, Cancer research.

[39]  D. C. Edwards,et al.  Increased toxicity of diphtheria toxin for human lymphoblastoid cells following covalent linkage to anti-(human lymphocyte) globulin or its F(ab')2 fragment. , 1980, European journal of biochemistry.

[40]  G. Gregoriadis.  Tailoring liposome structure , 1980, Nature.

[41]  G. Gregoriadis,et al.  Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. , 1980, The Biochemical journal.

[42]  N. Rooijen,et al.  Liposomes in immunology: Evidence that their adjuvant effect results from surface exposition of the antigens , 1980 .

[43]  H. Hemker,et al.  ORAL TREATMENT OF HÆMOPHILIA A BY GASTROINTESTINAL ABSORPTION OF FACTOR VIII ENTRAPPED IN LIPOSOMES , 1980, The Lancet.

[44]  Tyrrell Da,et al.  Liposomes--bags of potential. , 1980 .

[45]  M. Furusawa.  Cellular microinjection by cell fusion: technique and applications in biology and medicine. , 1980, International review of cytology.

[46]  S. K. Goolamali,et al.  Experiences after long-term treatment of a type I Gaucher disease patient with liposome-entrapped glucocerebroside: beta-glucosidase. , 1980, Birth defects original article series.

[47]  R. Watts,et al.  The treatment of lysosomal storage diseases by fibroblast transplantation: some preliminary observations. , 1980, Birth defects original article series.

[48]  G. Gregoriadis.  Targeting of drugs: possibilities in viral chemotherapy and prophylaxis. , 1980, Pharmacology & therapeutics.

[49]  R. Zachman,et al.  Pulmonary Uptake of Liposomal Phosphatidylcholine , 1980, Pediatric Research.

[50]  D. Martin,et al.  Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes. , 1980, The Journal of clinical investigation.

[51]  A. Schindler,et al.  Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters. , 1979, Journal of pharmaceutical sciences.

[52]  I. Sjöholm,et al.  Acrylic microspheres in vivo. II. The effect in rat of L-asparaginase given in microparticles of polyacrylamide. , 1979, The Journal of pharmacology and experimental therapeutics.

[53]  F. Szoka,et al.  Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes. , 1979, Cancer treatment reports.

[54]  D. Neville,et al.  Ricin linked to monophosphopentamannose binds to fibroblast lysosomal hydrolase receptors, resulting in a cell-type-specific toxin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[55]  E. Buddecke,et al.  Desialized low-density lipoprotein regulates cholesterol metabolism in receptor-deficient fibroblasts. , 1979, European journal of biochemistry.

[56]  N. Aronson,et al.  Uptake of asialo-glycophorin by the perfused rat liver and isolated hepatocytes. , 1979, Biochimica et biophysica acta.

[57]  G. Weissmann,et al.  Enzyme replacement via liposomes. Variations in lipid compositions determine liposomal integrity in biological fluids. , 1979, Biochimica et biophysica acta.

[58]  J. Flier,et al.  An Introduction to Receptors and Receptor Disorders , 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[59]  C. Alving,et al.  Sporozoite-induced malaria: therapeutic effects of glycolipids in liposomes. , 1979, Science.

[60]  O. H. Lowry,et al.  Enzymatic identification of mannose 6-phosphate on the recognition marker for receptor-mediated pinocytosis of beta-glucuronidase by human fibroblasts. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[61]  W. Shen,et al.  Poly (L-lysine) and poly (D-lysine) conjugates of methotrexate: different inhibitory effect on drug resistant cells. , 1979, Molecular pharmacology.

[62]  R. Juliano,et al.  Organ-selective action of an antitumor drug: pharmacologic studies of liposome-encapsulated beta-cytosine arabinoside administered via the respiratory system of the rat. , 1979, Journal of the National Cancer Institute.

[63]  G. Gregoriadis,et al.  Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. , 1979, Biochemical and biophysical research communications.

[64]  B. Hazleman,et al.  LIPOSOMES IN ARTHRITIS: A NEW APPROACH , 1979, The Lancet.

[65]  Y. Ikawa,et al.  Preparation of concanavalin A-ricin A-chain conjugate and its biologic activity against various cultured cells. , 1979, Journal of the National Cancer Institute.

[66]  K Mosbach,et al.  Preparation and application of magnetic polymers for targeting of drugs , 1979, FEBS letters.

[67]  L. Rome,et al.  Direct demonstration of binding of a lysosomal enzyme, alpha-L-iduronidase, to receptors on cultured fibroblasts. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[68]  J. Powers,et al.  Albumin microspheres as carrier of an inhibitor of leukocyte elastase: potential therapeutic agent for emphysema. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[69]  R L Magin,et al.  Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors. , 1979, Science.

[70]  A. Andersson.  ISLET IMPLANTATION NORMALISES HYPERGLYCÆEMIA CAUSED BY STREPTOZOTOCIN-INDUCED INSULITIS Experiments in Mice , 1979, The Lancet.

[71]  C. Wiblin,et al.  The effect of chemical modification of L-asparaginase on its persistence in circulating blood of animals. , 1979, Biochemical pharmacology.

[72]  I. Fidler,et al.  Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes. , 1979, Cancer research.

[73]  T. Oeltmann,et al.  A hybrid protein containing the toxic subunit of ricin and the cell-specific subunit of human chorionic gonadotropin. I. Synthesis and characterization. , 1979, The Journal of biological chemistry.

[74]  R. Brady,et al.  Specific binding of 125I-labeled beta-hexosaminidase A to rat brain synaptosomes. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[75]  A. Tall,et al.  Interaction between unilamellar egg yolk lecithin vesicles and human high density lipoprotein. , 1979, Biochemistry.

[76]  V. Richardson,et al.  Radionuclide-labelled liposomes--a new lymph node imaging agent. , 1979, International journal of nuclear medicine and biology.

[77]  R. Anderson,et al.  Enzyme replacement therapy by fibroblast transplantation: long-term biochemical study in three cases of Hunter's syndrome. , 1979, The Journal of clinical investigation.

[78]  S. Kusumoto,et al.  Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant. , 1978, Science.

[79]  J. Parks,et al.  Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. , 1978, Biochimica et biophysica acta.

[80]  M. Wilchek,et al.  The effect in vivo of chemotherapeutic drug—antibody conjugates in two murine experimental tumor systems , 1978, International journal of cancer.

[81]  C. Alving,et al.  Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[82]  V. Richardson,et al.  POTENTIAL APPLICATIONS OF LIPOSOMES TO THERAPY * , 1978, Annals of the New York Academy of Sciences.

[83]  Deborah S. Smith,et al.  The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets. , 1978, The New England journal of medicine.

[84]  R. New,et al.  Antileishmanial activity of antimonials entrapped in liposomes , 1978, Nature.

[85]  G. Weissmann,et al.  The introduction of enzymes into cells by means of liposomes. , 1978, Journal of lipid research.

[86]  A. Trouet.  Perspectives in cancer research. Increased selectivity of drugs by linking to carriers. , 1978, European journal of cancer.

[87]  R. Desnick,et al.  Immunological evaluation of repeated administration of erythrocyte-entrapped protein to C3H/HeJ mice. , 1977, The Biochemical journal.

[88]  E. Beutler,et al.  Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[89]  G. Gregoriadis,et al.  The effect of liposomal lipid composition on the fate and effect of liposome-entrapped insulin and tubocurarine [proceedings]. , 1977, Biochemical Society transactions.

[90]  G. Gregoriadis,et al.  Fate of a liposome-associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissues. , 1977, Life sciences.

[91]  G. Gregoriadis,et al.  TREATMENT OF GAUCHER'S DISEASE WITH LIPOSOME-ENTRAPPED GLUCOCEREBROSIDE: β-GLUCOSIDASE , 1977, The Lancet.

[92]  G. Rowland,et al.  TREATMENT OF MELANOMA BY PASSIVE HUMORAL IMMUNOTHERAPY USING ANTIBODY DRUG SYNERGISM , 1977, The Lancet.

[93]  A. Lerner,et al.  Melanotropin–daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells , 1977, Nature.

[94]  A. Macdonald,et al.  Immunochemotherapy of malignant melanoma with chlorambucil-bound antimelanoma globulins: preliminary results in patients with disseminated disease. , 1977, Journal of the National Cancer Institute.

[95]  G. Gregoriadis.  Targeting of drugs , 1977, Nature.

[96]  K. Hattori,et al.  Concanavalin A as a carrier of daunomycin , 1977, Nature.

[97]  R. Ward,et al.  The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis. , 1977, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[98]  R. Stern,et al.  Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. , 1976, The New England journal of medicine.

[99]  G. Gregoriadis,et al.  HYPOGLYCÆMIC EFFECT OF LIPOSOME-ENTRAPPED INSULIN ADMINISTERED INTRAGASTRICALLY INTO RATS , 1976, The Lancet.

[100]  G. Gregoriadis.  The Carrier Potential of Liposomes in Biology and Medicine , 1976 .

[101]  G Gregoriadis,et al.  The carrier potential of liposomes in biology and medicine (second of two parts). , 1976, The New England journal of medicine.

[102]  R. Brady.  Inherited metabolic diseases of the nervous system. , 1976, Science.

[103]  V. Dubowitz,et al.  Use of liposomes in treating type II glycogenosis. , 1976, British medical journal.

[104]  A. Munthe-Kaas,et al.  Introduction of B-chain-inactivated ricin into mouse macrophages and rat Kupffer cells via their membrane Fc receptors , 1976, The Journal of experimental medicine.

[105]  T. Heath,et al.  FORMATION OF VIROSOMES FROM INFLUENZA SUBUNITS AND LIPOSOMES , 1975, The Lancet.

[106]  G. Gregoriadis,et al.  Liposomes as vehicles for the local release of drugs. , 1975, Clinical science and molecular medicine.

[107]  G. Gregoriadis,et al.  Homing of liposomes to target cells. , 1975, Biochemical Society transactions.

[108]  G. Gregoriadis.  Catabolism of glycoproteins. , 1975, Frontiers of biology.

[109]  A. Morell,et al.  The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. , 2006, Advances in enzymology and related areas of molecular biology.

[110]  P. Tulkens,et al.  Commentary. Lysosomotropic agents. , 1974, Biochemical pharmacology.

[111]  G Gregoriadis,et al.  Drug-carrier potential of liposomes in cancer chemotherapy. , 1974, Lancet.

[112]  G. Gregoriadis,et al.  Comparative effect and fate of non-entrapped and liposome-entrapped neuraminidase injected into rats. , 1974, The Biochemical journal.

[113]  R. Rubens.  Antibodies as carriers of anticancer agents. , 1974, Lancet.